High mosquito and human population densities, combined with mosquito breeding conditions, are the central cause for Zika virus.
An international clinical trial for a new HIV antibody, VRC01 begins in late spring at UAB as part of the Antibody Mediated Prevention study.
UAB assistant professor leads the way in providing therapy for HIV patients with chronic pain.
Researcher focused on HIV and STD prevention in women will lead UAB School of Medicine Division of Infectious Diseases.
UAB is recruiting postpartum women who are still lactating, for a study on the effects of the antiretroviral drug used to prevent HIV transmission.
UAB's David Freedman, M.D., a professor of infectious diseases and a leading expert on international medicine and emerging diseases, discusses the Zika virus, touching on who is at risk, how to prevent infection and the likelihood of an United States outbreak.
Two prominent faculty members from the UAB Department of Medicine have been elected to become members of the American Society for Clinical Investigation (ASCI).
A UAB study reconfirms that single-dose azithromycin remains an effective treatment for chlamydia, especially when drug adherence is an issue.
The UAB Undiagnosed Diseases Program, designed to help find answers for rare medical conditions, now has a clinic in Children’s of Alabama.
UAB researchers collaborated on a study showing a blood test for chlamydia might be valuable in screening infertile women for pregnancy outcomes.
Page 1 of 4